AMPH Message Board Post 2286446 | Amphastar Pharmaceuticals...
home / stock / amph / amph message board
AviseAnalytics
Member
Posted on: Mar/12/2023 21:32:53
Source: mwn
AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITIES
$AMPH
Excited to share an article about Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company focusing primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation and intranasal products.
Amphastar recently received approval for its New Drug Application (NDA) for naloxone hydrochloride nasal spray 4mg - this is expected to strengthen its already diversified product portfolio further and bring in even more revenue opportunities for the Company.
https://www.aviseanalytics.com/amphastar-new-fda-approval-opens-a-floodgate-of-opportunities/
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
Market:
Amphastar Pharmaceuticals Inc. Website:
-
At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the ...
- AMPH - Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside c...
-
2024-03-20 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...